Literature DB >> 7008712

Detection of anti-dsDNA as diagnostic tool.

A J Swaak, J Groenwold, L A Aarden, T E Feltkamp.   

Abstract

The diagnostic significance of anti-dsDNA determinations was evaluated in 2 different groups of patients. When the immunofluorescence technique (IFT) with Crithidia luciliae and the Farr assay with 3H-labelled-PM2 DNA were applied to a selected panel of 536 sera from patients with various well-defined autoimmune diseases, positive results were obtained only with serum samples from patients with systemic lupus erythematosus (SLE). On the other hand when we screened 4431 sera sent to our laboratory for diagnostic reasons, we observed a high incidence of antibodies to dsDNA in patients who did not fulfil the preliminary American Rheumatism Association's criteria for SLE and did not have the diagnosis SLE. Furthermore, a significant number of the positive sera showed peculiar behaviour in that they were positive only in the IFT on Crithidia luciliae and not in the Farr assay.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7008712      PMCID: PMC1000654          DOI: 10.1136/ard.40.1.45

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  18 in total

1.  Immunology of DNA. II. The effect of size and structure of the antigen on the Farr assay.

Authors:  L A Arden; F Lakmaker; T E Feltkamp
Journal:  J Immunol Methods       Date:  1976       Impact factor: 2.303

2.  Antibodies to DNA in patients with rheumatoid arthritis and juvenile rheumatoid arthritis.

Authors:  C Bell; N Talal; P H Schur
Journal:  Arthritis Rheum       Date:  1975 Nov-Dec

3.  Immunology of DNA. I. The influence of reaction conditions on the Farr assay as used for the detection of anti-ds DNA.

Authors:  L A Aarden; F Lakmaker; T E Feltkamp
Journal:  J Immunol Methods       Date:  1976       Impact factor: 2.303

4.  Antibodies to native DNA in discoid lupus erythematosus.

Authors:  P Davis; B Atkins; G R Hughes
Journal:  Br J Dermatol       Date:  1974-08       Impact factor: 9.302

5.  Native DNA binding in rheumatoid arthritis.

Authors:  P G Rochmis; H Palefsky; M Becker; H Roth; N J Zvaifler
Journal:  Ann Rheum Dis       Date:  1974-07       Impact factor: 19.103

6.  Serum DNA binding activity in healthy subjects and in rheumatic disease.

Authors:  P Hasselbacher; E C LeRoy
Journal:  Arthritis Rheum       Date:  1974 Jan-Feb

7.  Measurement of serum DNA-binding activity in systemic lupus erythematosus.

Authors:  T Pincus; P H Schur; J A Rose; J L Decker; N Talal
Journal:  N Engl J Med       Date:  1969-09-25       Impact factor: 91.245

Review 8.  The specificity and applications of antibodies to helical nucleic acids.

Authors:  B D Stollar
Journal:  CRC Crit Rev Biochem       Date:  1975-05

9.  Immunology of DNA. III. Crithidia luciliae, a simple substrate for the determination of anti-dsDNA with the immunofluorescence technique.

Authors:  L A Aarden; E R de Groot; T E Feltkamp
Journal:  Ann N Y Acad Sci       Date:  1975-06-30       Impact factor: 5.691

10.  An immunofluorescence assay for double-stranded DNA antibodies using the Crithidia luciliae kinetoplast as a double-stranded DNA substrate.

Authors:  R D Sontheimer; J N Gilliam
Journal:  J Lab Clin Med       Date:  1978-04
View more
  17 in total

1.  Structure and function of anti-DNA autoantibodies derived from a single autoimmune mouse.

Authors:  M J Shlomchik; A H Aucoin; D S Pisetsky; M G Weigert
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

2.  Reactive oxygen species modify human DNA, eliciting a more discriminating antigen for the diagnosis of systemic lupus erythematosus.

Authors:  S Blount; H Griffiths; P Emery; J Lunec
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

3.  Anti-DNA immunoassay.

Authors:  D J Lea; R N Hobbs; D J Ward
Journal:  J Clin Pathol       Date:  1984-03       Impact factor: 3.411

Review 4.  Antinuclear antibody profiles in relation to specific disease manifestations of systemic lupus erythematosus.

Authors:  A J Swaak; V Huysen; J C Nossent; R J Smeenk
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

Review 5.  A comparison of assays used for the detection of antibodies to DNA.

Authors:  R Smeenk; K Brinkman; H van den Brink; T Swaak
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

6.  Serum levels of soluble forms of T cell activation antigens CD27 and CD25 in systemic lupus erythematosus in relation with lymphocytes count and disease course.

Authors:  A J Swaak; R Q Hintzen; V Huysen; H G van den Brink; J T Smeenk
Journal:  Clin Rheumatol       Date:  1995-05       Impact factor: 2.980

7.  Measurement of serum DNA binding in chronic active hepatitis and systemic lupus erythematosus using the Farr assay.

Authors:  K M Pollard; R Steele; S Hogg; J Webb
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

Review 8.  Clinical significance of antibodies to double stranded DNA (dsDNA) for systemic lupus erythematosus (SLE).

Authors:  T Swaak; R Smeenk
Journal:  Clin Rheumatol       Date:  1987-06       Impact factor: 2.980

9.  Detection of antibodies to DNA: a technical assessment.

Authors:  R Smeenk; M Hylkema
Journal:  Mol Biol Rep       Date:  1992-11       Impact factor: 2.316

Review 10.  Anti-dsDNA: choice of assay in relation to clinical value.

Authors:  R J Smeenk; H G van den Brink; K Brinkman; R M Termaat; J H Berden; A J Swaak
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.